Bovie Medical Corporation to Participate in the 9th Annual Craig-Hallum Alpha Select Conference
October 31 2018 - 4:05PM
Business Wire
Bovie Medical Corporation (NYSEMKT:BVX) (the “Company”),
a medical technology company and the developer of J-Plasma®, a
patented surgical product marketed and sold under the Renuvion™
Cosmetic Technology brand in the cosmetic surgery market, today
announced that management will participate in the 9th Annual
Craig-Hallum Alpha Select Conference at the Sheraton New York Times
Square Hotel in New York, New York. Management will host one-on-one
meetings with investors at the conference on Thursday, November
15.
About Bovie Medical
Corporation:
Bovie Medical Corporation is a medical technology company and
the developer of J-Plasma® (marketed and sold under the Renuvion™
Cosmetic Technology brand in the cosmetic surgery market), a
patented plasma-based surgical product for cutting, coagulation and
ablation of soft tissue. J-Plasma technology utilizes a helium
ionization process to produce a stable, focused beam of plasma that
provides surgeons with greater precision, and minimal invasiveness.
The Company also leverages its expertise through original equipment
manufacturing (OEM) agreements with other medical device
manufacturers. For further information about the Company and its
products, please refer to the Bovie Medical Corporation website at
www.boviemedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181031005179/en/
Investor
Relations:Westwicke Partners on behalf of Bovie
Medical CorporationMike Piccinino,
CFA443-213-0500investor.relations@boviemed.com
Bovie (AMEX:BVX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bovie (AMEX:BVX)
Historical Stock Chart
From Apr 2023 to Apr 2024